Estimation of diabetes risk in Brazilian population by typing for polymorphisms in HLA-DR-DQ, INS and CTLA-4 genes

Disease Markers

Volumn 21, Issue 3, 2005, Pages 139-145

  Hauache, Omar M ^a,b   Reis, André F ^a,b   Oliveira, Carolina S V ^a   Vieira, José Gilberto H ^a,b   Sjöroos, Minna ^c   Ilonen, Jorma ^d  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Fleury   (Brazil)

^c PerkinElmer Finland Oy   (Finland)

^d UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA DQ ANTIGEN; HLA DR ANTIGEN; INSULIN;

ARTICLE; BRAZIL; DIABETES MELLITUS; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC CODE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 27644467471     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2005/684123     Document Type: Article

References (31)

1. L.L. Field, Genetic linkage and association studies of Type I diabetes: challenges and rewards, Diabetologia 45 (2002), 21-35.
2. P.H. Moghaddam, P. deKnijf, B.O. Roep, B. VanderAuwera, A. Naipal, F. Gorus, F. Schuit and M.J. Giphart, Genetic structure of IDDM1: Two separate regions in the major histocompatibility complex contribute to susceptibility or protection, Diabetes 47 (1998), 263-269.
3. S. Nejentsev, Z. Gombos, A.P. Laine, R. Veijola, M. Knip, O. Simell, O. Vaarala, H.K. Akerblom and J. Ilonen, Non-class IIHLA gene associated with type 1 diabetes maps to the 240-kb region near HLA-B, Diabetes 49 (2000), 2217-2221.
4. P. Zavattari, R. Lampis, C. Motzo, M. Loddo, A. Mulargia, M. Whalen, M. Maioli, E. Angius, J.A. Todd and F. Cucca, Conditional linkage disequilibrium analysis of a complex disease superlocus, IDDM1 in the HLA region, reveals the presence of independent modifying gene effects influencing the type 1 diabetes risk encoded by the major HLA-DQB1,-DRB1 disease loci. Human Molecular Genetics 10 (2001), 881-889.
5. B.A. Lie, J.A. Todd, F. Pociot, J. Nerup, H.E. Akselsen, G. Joner, K. Dahl Jorgensen, K.S. Ronningen, E. Thorsby and D.E. Undlien, The predisposition to type 1 diabetes linked to the human leukocyte antigen complex includes at least one non-class II gene, Am J Hum Genet 64 (1999), 793-800.
6. H.A. Erlich, J.I. Rotter, J.D. Chang, S.J. Shaw, L.J. Raffel, W. Klitz, T.L. Bugawan and A. Zeidler, Association of HLA-DPB1(*)0301 with IDDM in Mexican-Americans, Diabetes 45 (1996), 610-614.
7. A. Kupila, P. Muona, T. Simell, H. Arvilommi, H. Savolainen, A.-M. Hämäläinen, S. Korhonen, T. Kimpimäki, M. Sjöroos, J. Ilonen, M. Knip and O. Simell, Feasibility of genetic and immunological prediction of type 1 diabetes in a population-based birth cohort, Diabetologia 44 (2001), 290-297.
8. M. Rewers, T.L. Bugawan, J.M. Norris, A. Blair, B. Beaty, M. Hoffman, R.S. McDuffie, Jr., R.F. Hamman, G. Klingensmith, G.S. Eisenbarth and H.A. Erlich, Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY), Diabetologia 39 (1996), 807-812, Issn: 0012-186x.
9. M. Sjöroos, A. Iitiä, J. Ilonen, H. Reijonen and T. Lövgren, Triple-label hybridization assay for type-1 diabetes-related HLA alleles, BioTechniques 18 (1995), 870-877.
10. S. Nejentsev, M. Sjöroos, T. Soukka, M. Knip, O. Simell, T. Lövgren and J. Ilonen, Population based genetic screening for type 1 diabetes risk in Finland: Selective genotyping of the markers in the HLA-DQB1, -DQA1 and -DRB1 loci, Diabetic Med 16 (1999), 985-992.
11. R. Hermann, C. Bartsocas, G. Soltesz, A. Vazeou, P. Paschou, E. Bozas, A. Malamitsi-Puchner, O. Simell, M. Knip and J. lionen, Genetic screening for individuals at high risk for type 1 diabetes in the general population using class II alleles as disease markers. A comparison between three European populations with variable rates of disease incidence, Diab/Metabl Res Rev (2004), in press.
12. M. Laaksonen, T. Pastinen, M. Sjöroos, S. Kuokkanen, J. Ruutiainen, M.-L. Sumelahti, H. Reijonen, R. Salonen, J. Wikström, M. Panelius, J. Partanen, P.J. Tienari and J. Ilonen, HLA class II associated risk and protection against multiple sclerosis - a Finnish family study, J. Neuroimmunol. 122 (2002), 140-145.
13. R. Hermann, H. Turpeinen, A.P. Laine, R. Veijola, M. Knip, O. Simell, I. Sipila, H.K. Akerblom and J. Ilonen, HLA DR-DQ-encoded genetic determinants of childhood-onset type 1 diabetes in Finland: An analysis of 622 nuclear families, Tissue Antigens 62 (2003), 162-169.
14. A.P. Laine, R. Hermann, M. Knip, O. Simell, H.K. Åkerblom and J. Ilonen, HLA genotype has a modest effect on the insulin gene polymorphism-associated susceptibility to Type 1 diabetes in the Finnish population, Tissue Antigens 63 (2004), 72-74.
15. A.P. Lambert, K.M. Gillespie, G. Thomson, H.J. Cordell, J.A. Todd, E.A. Gale and P.J. Bingley, Absolute risk of childhood-onset type 1 diabetes defined by human leukocyte antigen class II genotype: a population-based study in the United Kingdom, J Clin Endocrinol Metab 89 (2004), 4037-4043.
16. R.F. Schipper, B.P. Koeleman, G.J. Bruining, G.M. Schreuder, W. Verduijn, R.R. De Vries and B.O. Roep, HLA class II associations with Type 1 diabetes mellitus: a multivariate approach, Tissue Antigens 57 (2001), 144-150.
17. F. Cucca, R. Lampis, F. Frau, D. Macis, E. Angius, P. Masile, M. Chessa, P. Frongia, M. Silvetti, A. Cao, S. Devirgiliis and M. Congia, The distribution of DR4 haplotypes in Sardinia suggests a primary association of type I diabetes with DRB1 and DQB1 loci, Hum. Immunol. 43 (1995), 301-308.
18. B.O. Roep, R. Schipper, W. Verduyn, G.J. Bruining, G.M. Schreuder and R.R. de Vries, HLA-DRB1*0403 is associated with dominant protection against IDDM in the general Dutch population and subjects with high-risk DQA1*0301-DQB1*0302/DQA1*0501-DQB1*0201 genotype. Tissue Antigens 54 (1999), 88-90.
19. M. Karvonen, M. Viik Kajander, E. Moltchanova, I. Libman, R. LaPorte and J. Tuomilehto, Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group, Diabetes Care 23 (2000), 1516-1526.
20. D.L. Eizirik, C.M. Monteiro, J.C. Voltarelli and M.C. Foss, Frequency of HLA antigens in a Brazilian type I diabetic population, Braz J Med Biol Res 20 (1987), 533-537.
21. W.M.G. Volpini, G.V. Testa, S.B.D. Marques, L.I. Alves, M.E.R. Silva, S.A. Dib, G. Guerra, M. Paulino, S. Marini, L.B.L. Persoli and S. Caillat-Zucman, Family-based association of HLA class II alleles and haplotypes with type I diabetes in Brazilians reveals some characteristics of a highly diversified population, Human Immunology 62 (2001), 1226-1233.
22. A.P. Femandes, P. Louzada-Junior, M.C. Foss and E.A. Donadi, HLA-DRB1, DQB1, and DQA1 allele profile in Brazilian patients with type 1 diabetes mellitus, Ann N Y Acad Sci 958 (2002), 305-308.
23. D.E. Undlien, T. Friede, H.G. Rammensee, G. Joner, K. Dahl-Jorgensen, O. Sovik, H.E. Akselsen, I. Knutsen, K.S. Ronningen and E. Thorsby, HLA-encoded genetic predisposition in IDDM: DR4 subtypes may be associated with different degrees of protection, Diabetes 46 (1997), 143-149.
24. M.E. Moraes, M. Fernandez-Vina, I. Salatiel, S. Tsai, J.R. Moraes and P. Stastny, HLA Class-II DNA Typing in two Brazilian Populations, Tissue Antigens 41 (1993), 238-242.
25. A. Petrone, T.L. Bugawan, C.A. Mesturino, L. Nistico, A. Galgani, G. Giorgi, I. Cascino, H.A. Erlich, U. Di Mario and R. Buzzetti, The distribution of HLA class II susceptible/protective haplotypes could partially explain the low incidence of type 1 diabetes in continental Italy (Lazio region), Tissue Antigens 58 (2001), 385-394.
26. J.A. Noble, A.M. Valdes, M. Cook, W. Klitz, G. Thomson and H.A. Erlich, The role of HLA class II genes in insulin-dependent diabetes mellitus: Molecular analysis of 180 Caucasian, multiplex families, American Journal of Human Genetics 59 (1996), 1134-1148.
27. D.E. Undlien, I. Kockum, K.S. Ronningen, R. Lowe, C.B. Saanjeevi, J. Graham, B.A. Lie, H.E. Akselsen, A. Lernmark and E. Thorsby, HLA associations in type 1 diabetes among patients not carrying high-risk DR3-DQ2 or DR4-DQ8 haplotypes, Tissue Antigens 54 (1999), 543-551.
28. O. Cinek, S. Kolouskova, M. Snajderova, Z. Sumnik, P. Sedlakova, P. Drevinek, J. Varinec and K.S. Ronningen, HLA class II genetic association of type 1 diabetes mellitus in Czech children, Pediatric Diabetes (2001), 98-102.
29. R. Buzzetti, A. Galgani, A. Petrone, M.L. Del Buono, H.A. Erlich, T.L. Bugawan, R. Lorini, F. Meschi, G. Multari, P. Pozzilli, M. Locatelli, G. Bottazzo and U. Di Mario, Genetic prediction of type 1 diabetes in a population with low frequency of HLA risk genotypes and low incidence of the disease (the DIABFIN study), Diabetes Metab Res Rev 20 (2004), 137-143.
30. R. Hermann, C.S. Bartsocas, G. Soltesz, A. Vazeou, P. Paschou, E. Bozas, A. Malamitsi-Puchner, O. Simell, M. Knip and J. Ilonen, Genetic screening for individuals at high risk for type 1 diabetes in the general population using HLA Class II alleles as disease markers. A comparison between three European populations with variable rates of disease incidence, Diabetes Metab Res Rev 20 (2004), 322-329.
31. J. Alves-Silva, M. da Silva Santos, P.E. Guimaraes, A.C. Ferreira, H.J. Bandelt, S.D. Pena and V.F. Prado, The ancestry of Brazilian mtDNA lineages, Am J Hum Genet 67 (2000), 444-461.